← Back to Search

Behavioral Intervention

Technology-Assisted Language Intervention for Hearing Loss-related Language Delay (TALI Trial)

N/A
Recruiting
Led By Jareen Meinzen-Derr
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Currently receiving speech-language therapy
Age 3-10 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

TALI Trial Summary

This trial is testing whether a technology intervention can help improve language development for deaf or hard of hearing children.

Who is the study for?
This trial is for children aged 3-10 with moderate to profound bilateral hearing loss and a language deficit. They must be receiving speech-language therapy, have an IQ within the normal range, and speak English as their primary language. Children with mild or unilateral hearing loss, severe communication disorders like autism, nonverbal IQ below 80, or significant motor impairments cannot participate.Check my eligibility
What is being tested?
The study compares two approaches: one uses technology-assisted language intervention tools designed for deaf or hard of hearing children; the other follows standard treatment without these tools. Kids are randomly assigned to either group to see which method better improves their language skills.See study design
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, traditional side effects are not expected. However, there may be differences in individual experiences based on interaction with the technology.

TALI Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently undergoing speech-language therapy.
Select...
I am between 3 and 10 years old.

TALI Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Evaluation of Language Fundamentals-5th edition
Mean Length of Utterance in morphemes
Mean Turn Length
+1 more
Secondary outcome measures
Clinical Evaluation of Language Fundamentals-5th edition-pragmatics profile
Expressive Vocabulary Test 2nd edition

TALI Trial Design

2Treatment groups
Active Control
Group I: Technology Assisted Language Intervention (TALI)Active Control1 Intervention
Augmentative and alternative communication software incorporated into active speech-language therapy
Group II: Treatment as UsualActive Control1 Intervention
Speech language therapy child is typically receiving (no change to current care)

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiLead Sponsor
814 Previous Clinical Trials
6,531,467 Total Patients Enrolled
4 Trials studying Language Development
416 Patients Enrolled for Language Development
Jareen Meinzen-DerrPrincipal InvestigatorChildren's Hospital Medical Center, Cincinnati

Media Library

Technology-assisted Language Intervention (TALI) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04857255 — N/A
Language Development Research Study Groups: Technology Assisted Language Intervention (TALI), Treatment as Usual
Language Development Clinical Trial 2023: Technology-assisted Language Intervention (TALI) Highlights & Side Effects. Trial Name: NCT04857255 — N/A
Technology-assisted Language Intervention (TALI) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04857255 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age limit for this investigation?

"This clinical trial welcomes participants aged 3 to 10 years old."

Answered by AI

How many participants have been accepted into this investigation?

"Affirmative, the details published on clinicaltrials.gov suggests that this medical investigation is actively seeking participants to enrol in the trial. It was initially posted on October 15th 2020 and has since been revised as recently as March 18th 2022. This project requires 114 individuals from two different sites for completion."

Answered by AI

Are participants currently being recruited for this clinical experiment?

"According to records on clinicaltrials.gov, this medical research is presently seeking volunteers; it was initially uploaded onto the site in October 2020 and most recently updated in March of 2022."

Answered by AI

What prerequisites must a person meet to participate in this trial?

"For this clinical study, 114 patients with bilateral deafness from the ages of 3 to 10 are being recruited. In order for applicants to be eligible they must fulfill a number of requisites such as presenting moderate or profound levels of hearing loss, having an identified language deficit according to their nonverbal IQ and language standard scores ratio or difference between these two metrics, and currently undergoing speech-language therapy."

Answered by AI
~18 spots leftby Dec 2024